Journal Article Summary
The article examines the effectiveness of adding atypical antipsychotics to the treatment of obsessive-compulsive disorder (OCD) in patients who have not responded to selective serotonin reuptake inhibitors (SSRIs). This topic is significant because OCD can be a debilitating condition, and many patients do not achieve relief from symptoms with SSRIs alone. The study aims to provide clarity on whether these antipsychotic medications can offer additional benefits and to guide treatment options for those who are resistant to standard therapies.
The researchers conducted a systematic review and meta-analysis of double-blind randomized controlled trials involving adults with OCD who had not responded adequately to SSRIs or clomipramine. They focused on studies that measured outcomes using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). The findings indicated that aripiprazole showed significant short-term effectiveness, while risperidone also had a modest benefit. However, there was no evidence supporting the use of olanzapine or quetiapine as effective treatments in this context.
Despite these findings, the study has limitations, including small sample sizes and a lack of long-term follow-up data. Patients and caregivers should be cautious about the potential risks associated with antipsychotic medications, such as weight gain and metabolic issues. It is essential for individuals considering these treatments to discuss them thoroughly with a healthcare professional, including the potential benefits and risks, and to explore other treatment options like cognitive behavioral therapy (CBT) or combining SSRIs with clomipramine before resorting to antipsychotics.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Veale David, Miles Sarah, Smallcombe Nicola, Ghezai Haben, Goldacre Ben, Hodsoll John. Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis. BMC Psychiatry 2014. DOI: 10.1186/s12888-014-0317-5. PMID: 25432131. PMCID: PMC4262998.
Featured Pill Pals Product
Risperidone 0.25 mg Tablets --- Generic For Risperdal --- Ajanta
Risperidone 0.25 mg Tablets — Generic For Risperdal — Ajanta is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
